Buy GW-501516 (Cardarine) Capsules
€ 37,95
Cardarine capsules contain GW-501516, a PPARδ research compound presented by Raw Lab Chems with seller-specified ≥98% purity. This formulated material is intended exclusively for controlled laboratory, analytical, and scientific research.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
GW-501516 (Cardarine) Capsules
Product Overview
Cardarine capsules contain GW-501516, a synthetic research compound also referenced as Cardarine, GW1516, Endurobol, and GSK-516. GW-501516 is encountered in scientific literature as a selective ligand of peroxisome proliferator-activated receptor delta (PPARδ).
Raw Lab Chems presents this material in capsule form with a seller-specified purity of ≥98%. The formulation is intended exclusively for laboratory, analytical, forensic, and appropriately authorized scientific investigation.
The capsule presentation should be distinguished from the molecular identity of GW-501516 itself. A formulated research capsule can contain excipients or other non-active formulation components, and no detailed excipient composition was supplied. Researchers should therefore document the complete formulation separately from chemical-reference information describing GW-501516.
The scientific history of GW-501516 includes experimental investigation of PPARδ signaling and metabolic pathways, as well as substantial toxicological and anti-doping interest. Those research contexts do not establish any therapeutic, athletic, weight-management, or other human-use application.
Chemical Identity & Classification
The supplied systematic name is 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid.
The supplied CAS number is 317318-70-0, with molecular formula C21H18F3NO3S2 and molecular weight of approximately 453.50 g/mol.
Common identifiers include GW-501516, GW1516, Cardarine, Endurobol, and GSK-516. For analytical records, systematic identifiers and the applicable CAS number provide clearer documentation than informal or catalog names alone.
GW-501516 is commonly described in scientific literature as a PPARδ ligand or agonist. This describes its research classification and molecular context rather than an approved application.
Researchers can consult PubChem when reviewing chemical identifiers and general reference information relevant to the compound.
Chemical & Physical Characteristics
The underlying compound is described in the supplied information as a white to off-white material. The product itself is a formulated capsule, and no verified Raw Lab Chems information was supplied concerning capsule color, dimensions, shell composition, excipients, fill characteristics, or other formulation-specific physical properties.
Accordingly, properties of the isolated chemical should not automatically be treated as specifications for the complete capsule.
The supplied source also contains quantitative solubility and temperature-dependent storage information. No Raw Lab Chems batch-specific documentation was supplied to validate those figures for the capsule formulation, so they are not presented as guaranteed specifications.
Researchers investigating formulated material should account for possible matrix effects from capsule components when selecting appropriate analytical procedures.
Purity & Analytical Verification
Raw Lab Chems presents Cardarine capsules with a seller-provided ≥98% purity specification for the research compound.
This specification should not be interpreted as independent certification, a statement of capsule-content uniformity, or evidence of a particular instrumental analysis. No Raw Lab Chems batch-specific analytical report was supplied.
Chromatographic, spectroscopic, and mass-spectrometric methods may be applicable when characterizing GW-501516 or formulated research materials. Techniques can include HPLC, LC-MS, NMR, and related methods where appropriate to the analytical objective and validated laboratory procedure.
The supplied third-party material claims HPLC/GC profiles, Certificates of Analysis, metrological traceability, and other quality documentation. Those claims are not transferred to Raw Lab Chems without corresponding evidence for the specific material.
Quality Control & Batch Integrity
Reliable research involving formulated compounds benefits from documentation of material identity, formulation, source, lot information, receipt date, storage history, and analytical observations.
For capsule-based research materials, compound purity and formulation uniformity represent separate analytical questions. A purity specification for GW-501516 does not independently establish uniform distribution among individual capsules.
No verified information was supplied concerning Raw Lab Chems manufacturing procedures, capsule-content uniformity testing, batch traceability, lot-to-lot consistency, third-party certification, or specific analytical quality-control procedures.
Researchers requiring these attributes should rely on documentation applicable to the specific batch rather than inferring them from the catalog description.
Safety, Handling & Laboratory Precautions
GW-501516 should be handled only by appropriately trained personnel in a controlled laboratory setting. Laboratory controls should be based on institutional risk assessment, applicable safety documentation, and the precise research activity being performed.
The scientific safety history of GW-501516 is particularly relevant. Development of the compound did not result in an approved therapeutic product, and adverse findings, including tumor findings in animal toxicology studies, have been reported. This toxicological history should be considered when developing laboratory risk-management procedures.
Appropriate PPE, containment, ventilation, contamination controls, and procedures for accidental exposure should be established through applicable laboratory protocols.
The material should be secured against unauthorized access and kept away from children, pets, food, beverages, and non-research environments.
Packaging, Labeling & Storage
The supplied information establishes that the material is presented in capsule form. No verified Raw Lab Chems specifications were supplied concerning capsule shell composition, bottle or container material, sealing configuration, external packaging, or label format.
Claims in the third-party source concerning cold-chain handling, double-sealed packaging, and other specialized logistics are not attributed to Raw Lab Chems.
The source recommends dry, dark storage and provides additional temperature-related conditions. However, no Raw Lab Chems formulation-specific stability study was supplied to establish a validated storage temperature or shelf life for the capsules.
Researchers should follow documentation applicable to the actual material, relevant SDS information, and institutional chemical-storage requirements. Storage history should be recorded when environmental conditions could affect later analytical observations.
Intended Research Use & Market Positioning
GW-501516 is encountered in research involving PPARδ signaling, nuclear-receptor pharmacology, analytical chemistry, toxicology, and anti-doping science. Laboratory investigation may also involve chemical identification, method development, reference characterization, or analysis of formulated research materials.
The compound’s relationship to sports and endurance research should be interpreted strictly as scientific and regulatory context. This listing does not promote athletic performance, endurance enhancement, bodybuilding, fat loss, metabolic modification, or other personal applications.
Researchers examining related compounds can separately review Raw Lab Chems GW-0742 Powder and GW-0742 Capsules. These are distinct research materials and should not be considered chemically or analytically interchangeable with GW-501516.
The Raw Lab Chems GW-501516 Cardarine capsule research listing provides the catalog reference for this formulation.
No medical, therapeutic, diagnostic, veterinary, bodybuilding, athletic-performance, weight-management, cosmetic, recreational, or consumptive application is represented by this research description.
Ordering, Availability & Fulfillment
Institutional procurement of Cardarine capsules should begin with confirmation of the required formulation, documentation needs, institutional authorization, and applicable jurisdictional or organizational restrictions.
No verified Raw Lab Chems information was supplied concerning current inventory, package counts, dispatch schedules, geographic delivery coverage, courier services, tracking, payment methods, or specialized fulfillment arrangements.
Commercial claims in the supplied third-party material concerning stock, European shipping, same-day dispatch, discreet packaging, cryptocurrency payments, and delivery times are therefore not presented as Raw Lab Chems policies.
Researchers and institutions should independently establish whether acquisition, possession, import, export, transfer, storage, and investigation of GW-501516 are permitted and appropriately authorized before procurement.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
GW-501516 has a significant anti-doping and toxicological research context. Regulatory treatment can differ according to jurisdiction, activity, and applicable institutional rules.
Researchers and institutions are responsible for identifying and complying with requirements governing acquisition, possession, import, export, transfer, storage, security, research, and disposal.
A research-use designation does not establish universal legality, approval for clinical use, suitability as a dietary supplement, or exemption from anti-doping, chemical-control, institutional, or other applicable requirements.
You must be logged in to post a review.

Reviews
There are no reviews yet.